Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells

[1]  Xiaohui Xu,et al.  Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells , 2013, BMC Cancer.

[2]  Massimo Broggini,et al.  Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. , 2012, Cancer treatment reviews.

[3]  S. Dangi‐Garimella,et al.  Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression. , 2012, The Journal of surgical research.

[4]  Xiaohui Xu,et al.  Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells , 2012, Laboratory Investigation.

[5]  J. Nör,et al.  The biology of head and neck cancer stem cells. , 2012, Oral oncology.

[6]  A. Postigo,et al.  β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness , 2011, Proceedings of the National Academy of Sciences.

[7]  M. Nieto,et al.  The ins and outs of the epithelial to mesenchymal transition in health and disease. , 2011, Annual review of cell and developmental biology.

[8]  A. Dufour,et al.  Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration* , 2011, The Journal of Biological Chemistry.

[9]  R. Jain,et al.  Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. , 2011, Cancer research.

[10]  M. Hummel,et al.  Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma , 2011, PloS one.

[11]  B. Zhou,et al.  Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters , 2011, BMC Cancer.

[12]  Robert A. Weinberg,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[13]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[14]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[15]  G. Feldmann,et al.  Expression of the Transcription Factor Snail and Its Target Gene Twist Are Associated with Malignancy in Pheochromocytomas , 2009, Annals of Surgical Oncology.

[16]  Lesley A. Mathews,et al.  Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature , 2009, Clinical & Experimental Metastasis.

[17]  H. Shigeishi,et al.  Gene expression profiling to identify genes associated with high-invasiveness in human squamous cell carcinoma with epithelial-to-mesenchymal transition. , 2008, Cancer letters.

[18]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[19]  S. Zucker,et al.  Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer* , 2008, Journal of Biological Chemistry.

[20]  Vito Quaranta,et al.  A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro , 2008, BMC Cancer.

[21]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[22]  P. Neth,et al.  Scientific category: Stem cells in hematology MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines , 2006 .

[23]  Andrew J. Ewald,et al.  Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.

[24]  I. Weissman,et al.  Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.

[25]  A. Cano,et al.  New potential therapeutic targets to combat epithelial tumor invasion , 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[26]  S. Weiss,et al.  A cancer cell metalloprotease triad regulates the basement membrane transmigration program. , 2006, Genes & development.

[27]  Y. Itoh,et al.  MT1‐MMP: A key regulator of cell migration in tissue , 2006, IUBMB life.

[28]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[29]  G. Berx,et al.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. , 2006, Gastroenterology.

[30]  R. Weinberg,et al.  Exploring a new twist on tumor metastasis. , 2006, Cancer research.

[31]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[32]  A. Carvalho,et al.  Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database , 2005, International journal of cancer.

[33]  Hiroshi Sato,et al.  Roles of membrane‐type matrix metalloproteinase‐1 in tumor invasion and metastasis , 2005, Cancer science.

[34]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[35]  Federación de Sociedades Españolas de Oncología.  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. , 2005 .

[36]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[37]  A. Strongin,et al.  Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. , 2004, Experimental cell research.

[38]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[39]  Motoharu Seiki,et al.  The cell surface: the stage for matrix metalloproteinase regulation of migration. , 2002, Current opinion in cell biology.

[40]  Y. Itoh,et al.  Matrix metalloproteinases in cancer. , 2002, Essays in biochemistry.

[41]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[42]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[43]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[44]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[45]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[46]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[47]  M. Seiki.  Membrane‐type matrix metalloproteinases , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[48]  Y. Itoh,et al.  MEMBRANE-TYPE MATRIX METALLOPROTEINASES , 2017 .

[49]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer Treatment and Research.

[50]  S. Taylor.  Head and neck cancer. , 1991, Cancer chemotherapy and biological response modifiers.

[51]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.